Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

Persistent depression following transient ischemic attack is associated with a 4-fold increase in 5-year all-cause mortality and higher disability.

A mini stroke or TIA is not harmless. Apollo-Neurologist Dr Sudhir Kumar warn it is one of the strongest predictors of a ...

Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...

Because of the trust you have with your patients, you are in a unique position to notice, evaluate, and act on neurologic and other conditions your patients experience. As you are interacting with ...

In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...